These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22806931)

  • 1. Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines.
    Abraham A; Habermann EB; Rothenberger DA; Kwaan M; Weinberg AD; Parsons HM; Gupta P; Al-Refaie WB
    Cancer; 2013 Jan; 119(2):395-403. PubMed ID: 22806931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers.
    Phelip JM; Molinié F; Delafosse P; Launoy G; Trétarre B; Bara S; Buémi A; Velten M; Danzon A; Ganry O; Bouvier AM; Grosclaude P; Faivre J
    Gastroenterol Clin Biol; 2010 Feb; 34(2):144-9. PubMed ID: 20079591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer.
    McKenzie S; Nelson R; Mailey B; Lee W; Chung V; Shibata S; Garcia-Aguilar J; Kim J
    Cancer; 2011 Dec; 117(24):5493-9. PubMed ID: 21692068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada.
    Lima IS; Yasui Y; Scarfe A; Winget M
    Cancer; 2011 Aug; 117(16):3833-40. PubMed ID: 21319156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
    Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
    J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
    Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
    J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant treatment for elderly patients with colon cancer. An observational study.
    Pasetto LM; Falci C; Basso U; Gasparini G; D'Andrea M; Bonginelli P; Bajetta E; Platania M; Alabiso O; Miraglia S; Bertona E; Oniga F; Biason R; Chetrì MC; Fedele P; Massara G; Romaniello I; Negru ME; Luchena G; Giordano M; Buzzi F; Ricottao R; Sienao S; Monfardini S
    Anticancer Res; 2008; 28(4C):2513-8. PubMed ID: 18751443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment.
    Winget M; Hossain S; Yasui Y; Scarfe A
    Cancer; 2010 Oct; 116(20):4849-56. PubMed ID: 20578180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
    Hong KD; Lee SI; Moon HY
    Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the adjuvant chemotherapy effect in elderly stage II and III colon cancer patients in an observational study.
    Kim KY; Cha IH; Ahn JB; Kim NK; Rha SY; Chung HC; Roh JK; Shin SJ
    J Surg Oncol; 2013 May; 107(6):613-8. PubMed ID: 23592499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
    Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
    Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
    Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
    Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008.
    van den Broek CB; Bastiaannet E; Dekker JW; Portielje JE; de Craen AJ; Elferink MA; van de Velde CJ; Liefers GJ; Kapiteijn E
    Acta Oncol; 2013 Jun; 52(5):941-9. PubMed ID: 23145507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
    Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
    BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer.
    Hsieh MC; Chiu YW; Velasco C; Wu XC; O'Flarity MB; Chen VW
    J Registry Manag; 2013; 40(4):180-7. PubMed ID: 24625772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
    Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA
    J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma?
    Bayraktar UD; Chen E; Bayraktar S; Sands LR; Marchetti F; Montero AJ; Rocha-Lima CM
    Cancer; 2011 Jun; 117(11):2364-70. PubMed ID: 24048783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of care along the cancer continuum: does receiving adequate lymph node evaluation for colon cancer lead to comprehensive postsurgical care?
    Parsons HM; Tuttle TM; Kuntz KM; Begun JW; McGovern PM; Virnig BA
    J Am Coll Surg; 2012 Sep; 215(3):400-11. PubMed ID: 22683070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
    Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
    Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.